HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insertion of a T next to the donor splice site of intron 1 causes aberrantly spliced mRNA in a case of infantile GM1-gangliosidosis.

Abstract
The lysosomal storage disorders GM1-gangliosidosis and Morquio B syndrome are caused by a complete or partial deficiency of acid beta-galactosidase. Here, we have characterized the mutation segregating in a family with two siblings affected by the severe infantile form of GM1-gangliosidosis. In total mRNA preparations derived from the patients' fibroblasts at least two aberrantly spliced beta-galactosidase transcripts (1 and 2) have been identified. Both transcripts contain a 20 nucleotide (nt) insertion derived from the 5' end of intron 1 of the beta-galactosidase gene. Furthermore, in transcript 2 sequences encoded by exon II are deleted during the splicing process. Comparison of the 20-nt insertion with wild-type intronic sequences indicated that in the genomic DNA of the patients an extra T nucleotide is present immediately downstream of the conserved GT splice donor dinucleotide of intron 1. Both patients are homozygous for the T nucleotide insertion. We propose that this single base insertion is the mutation responsible for aberrant splicing of beta-galactosidase pre-mRNA, giving rise to transcripts that cannot encode a normal protein.
AuthorsA Morrone, H Morreau, X Y Zhou, E Zammarchi, W J Kleijer, H Galjaard, A d'Azzo
JournalHuman mutation (Hum Mutat) Vol. 3 Issue 2 Pg. 112-20 ( 1994) ISSN: 1059-7794 [Print] United States
PMID8199591 (Publication Type: Case Reports, Journal Article)
Chemical References
  • RNA, Messenger
Topics
  • Base Sequence
  • Cells, Cultured
  • DNA Mutational Analysis
  • Female
  • Fetal Diseases (diagnosis, genetics)
  • Fibroblasts
  • Gangliosidosis, GM1 (genetics)
  • Genes
  • Humans
  • Infant, Newborn
  • Introns
  • Male
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • Pregnancy
  • Prenatal Diagnosis
  • RNA Splicing
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: